Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 83.7K | $149K | $1.78 | Jan 19, 2024 | Direct |
HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 65.8K | $142K | $2.15 | Jan 19, 2024 | Direct |
LA JOLLA PHARMACEUTICAL CO | Director | Common Stock | 0 | $6.23 | Aug 22, 2022 | Direct | |
LA JOLLA PHARMACEUTICAL CO | Director | Stock Option (Right to Buy) | 0 | Aug 22, 2022 | Direct | ||
Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |